1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Rigorous Impact Evaluation of Programs to Prevent Teen Pregnancy and Achieve Optimal Health is sponsored by HHS Office of Population Affairs. This funding opportunity solicits applications for projects to rigorously evaluate promising interventions that contribute to adolescent optimal health and preventing teen pregnancy, sexually transmitted infections (STIs), behavioral risk factors underlying teen pregnancy, or ot…
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Rigorous Impact Evaluation of Programs to Prevent Teen Pregnancy and Achieve Optimal Health Simpler. Grants. gov uses Login.
gov to verify your identity and manage your account securely. You don't need a separate username or password for this site. Rigorous Impact Evaluation of Programs to Prevent Teen Pregnancy and Achieve Optimal Health Agency: Office of the Assistant Secretary for Health Assistance Listings: 93.
297 -- Teenage Pregnancy Prevention Program Last Updated: June 23, 2026 View version history on Grants. gov The Office of Population Affairs (OPA) announces the anticipated availability of funds for Fiscal Year (FY) 2026 grants under the authority of Division B, Title II of the Consolidated Appropriations Act, 2026 (Public Law 119-75).
This notice solicits applications for projects to rigorously evaluate promising interventions that contribute to adolescent optimal health and preventing teen pregnancy, sexually transmitted infections (STIs), behavioral risk factors underlying teen pregnancy, or other associated risk factors. OPA intends to make available approximately $8. 3 million for an estimated nine...
(9) grant awards for a period of up to five (5) years. The actual amount available will not be determined until enactment of the FY2027 federal budget.
The goal of this initiative is to identify effective interventions focused on body literacy and ensuring transparency and protection of parental rights for future replication by adolescent health practitioners and youth-serving professionals, and to disseminate the research findings and lessons learned to inform future studies.
Federally recognized Native American tribal governments Public and Indian housing authorities Special district governments City or township governments Nonprofits non-higher education with 501(c)(3) Other Native American tribal organizations Nonprofits non-higher education without 501(c)(3) Independent school districts Private institutions of higher education Public and state institutions of higher education For-profit organizations other than small businesses Grantor contact information File name Description Last updated AH-TP2-26-001_TPP_Tier_2_Rigorous_Impact_Evaluation.
pdf AH-TP2-26-001 TPP Tier 2 Rigorous Impact Evaluation. pdf Jun 23, 2026 01:38 PM UTC Link to additional information visit the OPA website at https://opa. hhs.
gov/grant-programs/funding-opportunities for details Archived: September 1, 2026 Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.
According to the current listing, eligibility includes: Nonprofit organizations (implied, as OPA funds a network of public and private nonprofit entities). Confirm the full requirements in the official notice before applying.
Rigorous Impact Evaluation of Programs to Prevent Teen Pregnancy and Achieve Optimal Health is funded by HHS Office of Population Affairs. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Schmidt Sciences' AI Impact on Jobs program supports rigorous interdisciplinary research on how generative AI and AI agents are reshaping employment, occupational tasks, wages, productivity, and labor markets. Funded scope includes empirical measurement of AI adoption across industries and occupations, task-level analyses of AI capabilities and displacement, longitudinal studies of worker outcomes, AI's effects on inequality and labor market polarization, evaluation of reskilling and transition programs, AI's role in entrepreneurship and small business productivity, and policy-relevant work on social safety nets and labor regulation in an AI economy.
IHI European HealthCare Incubator Network is sponsored by European Commission — Horizon Europe. Expected Impact: The action under this topic is expected to achieve the following impacts and contribute to the following EU policies/initiatives: deliver innovative, early technology solutions that contribute to addressing strategic unmet public health needs across multiple therapy areas to improve prevention, early diagnosis, and treatment; leverage the unique network and scale of IHI JU members to create a pipeline to support innovative startups in the health industry, fully integrated into European initiatives in support of start-ups and entrepreneurship; drive early cross-sector health R&D and innovation to strengthen the European healthcare industry’s global competitiveness, contributing to the EU Industrial Strategy and Pharmaceutical Strategy objectives; create a sustainable network of European healthcare incubators to guide and support highly talented and innovative early-stage companies; harness digital health and data-sharing technologies (e.g., AI and big data) to enable interoperable health solutions, contributing to the European Health Data Space (EHDS) and improved evidence based care;- the action should generate a portfolio of early‑stage companies that have undergone rigorous multi‑industry validation, significantly increasing their credibility with investors, regulators, and healthcare systems. This ‘industry quality seal’ should enhance the selected startups’ ability to secure follow‑on financing; by integrating corporate expertise into a pan‑European incubator network, the action should reduce fragmentation, support faster clinical and eventually commercial decision‑making, and enable more innovators to navigate regulatory and reimbursement pathways successfully. This should contribute to the objectives of the EU to accelerate the translation of research into deployable health technologies. The Network should serve as a feeder mechanism into wider EU support structures, ensuring that promising companies can transition smoothly into later‑stage funding and scale‑up opportunities. This complementarity should maximise the added value of EU public funding while avoiding duplication and reinforcing Europe’s position as a globally competitive hub for health innovation. The action under this topic should synergise with relevant EU programmes and contribute to several key EU strategies and policies: Life Science strategy, the proposed Biotech Act (especially the biotechnology development accelerators as referred to in article 5 of the Commission proposal), Industrial strategy, Pharmaceutical strategy, EU4Health Programme, Digital Europe Programme, Testing and Experimental Facility for Health AI and Robotic (TEF-Health), European Innovation Council (EIC) programmes, EU Competitive Compass, Choose Europe initiative, Startup and Scale-up strategy by the European Commission. Additionally, the action under this topic should synergise with the forthcoming European Startup and Scaleup Hubs and, in particular, encourage connection into the Network from the Call ‘European Startup and Scaleup Hub Pilot Call – HORIZON-EIE-2026-02-CONNECT-01’. Furthermore, the action has the potential to support Europe’s Beating Cancer Plan, EU Mission on Cancer, Healthier Together – EU Non-Communicable diseases initiative, Joint Action for Cardiovascular Disease and Diabetes in Europe, or the Cardiovascular Health Plan. Applicants should demonstrate in the proposal how these synergies will avoid duplication, ensure complementarity with existing EU efforts, and provide early-stage companies with continuity and scale up pathways. Expected Outcome: This call topic responds to the pressing need for a collaborative approach to accelerating the research-to-market pathway and fostering innovation and competitiveness in the European healthcare sector. Accordingly, the action under this topic must contribute to all of the following outcomes: 1. A sustainable European HealthCare Incubator Network (hereafter, the ‘Network’) linking incubators from t Programme areas: Global Challenges and European Industrial Competitiveness, Health, Innovative Health Initiative, Horizon Europe (HORIZON) Keywords: Competitiveness, innovation, research and development, Decrease technological and industrial risks, Health care, Incubator companies, Investment readiness, Related to SME and start-up support, SME support, Start-up companies, European HealthCare Incubator Network, IHI, IHI JU, Innovative Health Initiative, Innovative Health Initiative Joint Undertaking, Joint Undertaking Deadline stages: 2026-10-08, 2027-04-21
On August 25, 2026 a Ninth Circuit panel affirmed most of a sweeping injunction against HUD, DOT, and HHS grant conditions covering roughly $14 billion. The opinion sorts conditions into four buckets — and only one of them holds up. Here is what changed for every recipient of a federal award.
Read articleUSDA and HHS announced Harvest to Hallways on August 24, 2026: $50M in new cafeteria infrastructure funding on top of $20M in Equipment Assistance Grants, up to $25M more in Patrick Leahy Farm to School awards for FY2026, and $30M in HHS nutrition research. Each pot has a different applicant, a different route, and a different timeline. Here is how to position for all three before the notices post.
Read articleThe FY2026 Tribal Management Grant Program (HHS-2026-IHS-TMD-0001) funds four distinct project types — feasibility study, planning, evaluation study, and health management structure — with awards from $50,000 to $300,000 and no cost-share requirement. It is the deliberate on-ramp to ISDEAA Title I contracting and Title V compacting, and choosing the wrong project type is the most common way applicants lose it.
Read article